Categories AlphaGraphs, Earnings, Health Care
Biogen (BIIB) Q2 2024 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported its second quarter 2024 earnings results today.
Total revenue of $2.5 billion was flat at actual currency and up 1% at constant currency compared to the same period a year ago.
Net income attributable to Biogen Inc. was $583.6 million compared to $591.6 million last year.
GAAP EPS dropped 2% to $4.00 while adjusted EPS rose 31% to $5.28 compared to last year.
For the full year of 2024, the company expects total revenue to decline by a low-single digit percentage. Adjusted EPS is expected to be $15.75-16.25.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
